National Diabetes News
Can continuous glucose monitors benefit people without type 1 diabetes?
Continuous glucose monitors, or CGMs, have become increasingly popular with people who do not live with type 1 diabetes (T1D) as a way to observe the impact of activity and food on their blood-glucose levels. While increased visibility of T1D technology can help normalize an advanced way to manage what is often an invisible condition, can wearing a CGM benefit people without T1D? Breakthrough T1D takes a look.
This tiny implant could save diabetics from silent, deadly crashes
For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is injecting a hormone called glucagon.
As an emergency backup, for cases where patients may not realize that their blood sugar is dropping to dangerous levels, MIT engineers have designed an implantable reservoir that can remain under the skin and be triggered to release glucagon when blood sugar levels get too low.
FDA Clears twiist Automated Insulin Delivery System
Robert F. Kennedy Jr loves them. But do you really need a continuous glucose monitor?
A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, small patches that provide 24-hour insight into concentrations of sugar in the blood, could be a tool for Americans to “take control over their own health,” Health Secretary Robert F. Kennedy Jr. recently told federal lawmakers.
Type 2 diabetes linked to higher rates of debt, bankruptcy and foreclosure
Research reveals financial toll of living with type 2 diabetes
Consider the delicate web of fat in a Wagyu steak. The “marbling” that makes carnivore connoisseurs swoon is a visual heuristic for quality flavor. Now, a new study suggests the very same marbling of fat inside our own muscles points to trouble.
This condition, known as intramuscular adipose tissue, or IMAT, has long been recognized by scientists as a strong indicator of poor health. It’s linked to a wide range of diseases: obesity, Type 2 diabetes, neuromuscular disorders (including Duchenne muscular dystrophy) and neurogenerative conditions such as ALS. In some cases, clinicians can even track the progress of a disease by the amount of fat in muscle tissue.
